Industry & Regulation

Solabia Names Muriel Koch President and CEO to Lead Post-Mibelle Growth

Solabia appoints Muriel Koch as President and Chief Executive Officer
jarmoluk / pixabay

Solabia has appointed Muriel Koch as President and Chief Executive Officer, handing the top job to an executive with more than 30 years leading consumer brands across cosmetics and nutrition. She arrives from the NUXE Group, where she ran the business as Chief Executive Officer from 2019 to 2026, and she steps in at a moment when Solabia's identity as an ingredients supplier is changing fast.

Who is the new CEO?

Koch's track record splits cleanly into two chapters. At NUXE — the group behind France's leading natural cosmetics brand sold in pharmacies — she steered a group-wide transformation. That meant international development, a modernisation of the brand itself, and a stronger commitment to sustainability, with the source pointing specifically to responsible sourcing and traceability. For a supplier selling into natural-positioned brands, that curriculum vitae reads as directly relevant.

The earlier chapter ran more than 20 years at Nestlé, across Germany, France and the Benelux. There she managed global brands in confectionery, waters and infant nutrition, built businesses internationally and restored their profitability. Her final Nestlé role was General Manager of Nestlé Infant Nutrition for France and the Benelux. She is a graduate of EDHEC Business School.

What does this change for Solabia?

The headline answer sits with the Mibelle Biochemistry deal. In June 2026, Solabia completed its acquisition of the Swiss active ingredients specialist, a company known for plant-based innovation and advanced biotechnology. Combine Solabia's international footprint with Mibelle's expertise, the group argues, and Solabia now ranks among the world's leading independent players in cosmetic active ingredients.

Koch's stated mandate is twofold: she will lead the integration of Mibelle Biochemistry and drive the group's next phase of growth. For formulation teams and sourcing directors at customer brands, that signals the combined entity intends to compete harder for actives briefs on a global scale rather than region by region.

Where the strategy is pointed

Solabia, majority-owned by the pan-European private equity firm Astorg, is sharpening its focus on three core markets: cosmetics, nutrition and life sciences. Koch's dual background — cosmetics at NUXE, nutrition at Nestlé — maps almost exactly onto two of those three pillars, which is unlikely to be a coincidence.

The new CEO framed her priorities in her first comments. "On the brand side, I saw first-hand how much a product's success owes to the science behind its ingredients," Koch said. "Solabia combines that scientific excellence with a strong international footprint and, with Mibelle Biochemistry, now has an exceptional platform to serve brands worldwide. My priorities will be to bring our teams together, accelerate innovation and stay close to our customers."

That quote is worth parsing. A CEO who spent seven years running a pharmacy-channel beauty brand is telling customers she has sat on their side of the table, judging ingredient suppliers by what the science actually delivered at shelf.

The road ahead

Three priorities, explicitly stated: unify the teams, accelerate innovation, stay close to customers. All three will be tested against the practical grind of integrating a Swiss biotechnology specialist into a French-rooted, Astorg-backed group, while the merged actives platform chases a leading independent position worldwide. How quickly Koch turns combined capability into customer-facing launches will define her first year.

Source: Cosmetics Business

Share this article:

Sophie Lindqvist

Show full bio

Market editor covering people, launches and day-to-day practice in Clinical dermatology, inflammatory skin disease and biologics at Derm Field.

More from Sophie Lindqvist →

Related articles

« Previous articleNext article »